IBDEI03Y ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1144,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,1144,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,1144,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,1145,0)
 ;;=L97.919^^12^130^7
 ;;^UTILITY(U,$J,358.3,1145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1145,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer Unspec Part Right Lower Leg
 ;;^UTILITY(U,$J,358.3,1145,1,4,0)
 ;;=4^L97.919
 ;;^UTILITY(U,$J,358.3,1145,2)
 ;;=^5133688
 ;;^UTILITY(U,$J,358.3,1146,0)
 ;;=L97.929^^12^130^6
 ;;^UTILITY(U,$J,358.3,1146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1146,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer Unspec Part Left Lower Leg
 ;;^UTILITY(U,$J,358.3,1146,1,4,0)
 ;;=4^L97.929
 ;;^UTILITY(U,$J,358.3,1146,2)
 ;;=^5133689
 ;;^UTILITY(U,$J,358.3,1147,0)
 ;;=L98.499^^12^130^5
 ;;^UTILITY(U,$J,358.3,1147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1147,1,3,0)
 ;;=3^Non-Pressure Chr Skin Ulcer
 ;;^UTILITY(U,$J,358.3,1147,1,4,0)
 ;;=4^L98.499
 ;;^UTILITY(U,$J,358.3,1147,2)
 ;;=^5009591
 ;;^UTILITY(U,$J,358.3,1148,0)
 ;;=M15.8^^12^131^33
 ;;^UTILITY(U,$J,358.3,1148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1148,1,3,0)
 ;;=3^Polyosteoarthritis,Other
 ;;^UTILITY(U,$J,358.3,1148,1,4,0)
 ;;=4^M15.8
 ;;^UTILITY(U,$J,358.3,1148,2)
 ;;=^5010767
 ;;^UTILITY(U,$J,358.3,1149,0)
 ;;=F07.0^^12^131^22
 ;;^UTILITY(U,$J,358.3,1149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1149,1,3,0)
 ;;=3^Personality Change d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,1149,1,4,0)
 ;;=4^F07.0
 ;;^UTILITY(U,$J,358.3,1149,2)
 ;;=^5003063
 ;;^UTILITY(U,$J,358.3,1150,0)
 ;;=G62.9^^12^131^32
 ;;^UTILITY(U,$J,358.3,1150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1150,1,3,0)
 ;;=3^Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,1150,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,1150,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,1151,0)
 ;;=F43.10^^12^131^1
 ;;^UTILITY(U,$J,358.3,1151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1151,1,3,0)
 ;;=3^PTSD Unspec
 ;;^UTILITY(U,$J,358.3,1151,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,1151,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,1152,0)
 ;;=F43.12^^12^131^2
 ;;^UTILITY(U,$J,358.3,1152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1152,1,3,0)
 ;;=3^PTSD,Chr
 ;;^UTILITY(U,$J,358.3,1152,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,1152,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,1153,0)
 ;;=G20.^^12^131^19
 ;;^UTILITY(U,$J,358.3,1153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1153,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,1153,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,1153,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,1154,0)
 ;;=I73.9^^12^131^3
 ;;^UTILITY(U,$J,358.3,1154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1154,1,3,0)
 ;;=3^PVD,Unspecified
 ;;^UTILITY(U,$J,358.3,1154,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,1154,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,1155,0)
 ;;=I80.3^^12^131^28
 ;;^UTILITY(U,$J,358.3,1155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1155,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis Lower Extremities,Unspec
 ;;^UTILITY(U,$J,358.3,1155,1,4,0)
 ;;=4^I80.3
 ;;^UTILITY(U,$J,358.3,1155,2)
 ;;=^5007845
 ;;^UTILITY(U,$J,358.3,1156,0)
 ;;=J02.9^^12^131^24
 ;;^UTILITY(U,$J,358.3,1156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1156,1,3,0)
 ;;=3^Pharyngitis Acute,Unspec
 ;;^UTILITY(U,$J,358.3,1156,1,4,0)
 ;;=4^J02.9
 ;;^UTILITY(U,$J,358.3,1156,2)
 ;;=^5008130
 ;;^UTILITY(U,$J,358.3,1157,0)
 ;;=J18.9^^12^131^31
 ;;^UTILITY(U,$J,358.3,1157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1157,1,3,0)
 ;;=3^Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,1157,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,1157,2)
 ;;=^95632
